M&T Bank Corp Agios Pharmaceuticals, Inc. Transaction History

M&T Bank Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 29, 2020	SELL	$34.45 - $53.48 $10,335 - $16,043	-300 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$31.52 - $53.81 $9,456 - $16,143	300 New	300 $10.6 Million
Q2 2019 Aug 12, 2019	SELL	$46.17 - $68.1 $151,945 - $224,117	-3,291 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $151,122 - $222,701	3,291 New	3,291 $221,000
Q4 2018 Feb 01, 2019	SELL	$42.73 - $76.53 $158,357 - $283,620	-3,706 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$71.67 - $91.95 $2,221 - $2,850	-31 Reduced 0.83%	3,706 $285,000
Q2 2018 Aug 10, 2018	BUY	$73.22 - $99.55 $12,227 - $16,624	167 Added 4.68%	3,737 $315,000
Q1 2018 May 04, 2018	BUY	$59.83 - $86.53 $213,593 - $308,912	3,570 New	3,570 $293,000

244

59.9M

270K

332K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.94B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.